← Back to Analyst Consensus 
LAB Sell
STANDARD BIOTOOLS INC.
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 10, 2026 (15 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Nov 5, 2025 | TD Cowen | maintain | Hold → Hold | $1.35 | 54% |
| Feb 27, 2025 | Keybanc | downgrade | Overweight → Sector Weight | $0 | 53% |
| Oct 31, 2024 | TD Cowen | maintain | Buy → Buy | $2.5 | 54% |
| Aug 1, 2024 | TD Cowen | maintain | Buy → Buy | $2.75 | 54% |
| Apr 16, 2024 | TD Cowen | initiate | — → Buy | $3.5 | 54% |
| Apr 4, 2024 | Jefferies | initiate | — → Buy | $3.25 | 52% |
| Jul 12, 2023 | Keybanc | initiate | — → Overweight | $4 | 53% |
Price Target Trend
Apr 24, 2026 Latest: $1.35 Oct 25, 2026
EPS Estimates
0y $-0.10
Lo: $-0.10 Hi: $-0.10
1 analysts +1q $-0.02
Lo: $-0.02 Hi: $-0.02
1 analysts 0q $-0.02
Lo: $-0.02 Hi: $-0.02
1 analysts +1y $-0.16
Lo: $-0.16 Hi: $-0.16
1 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days